Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins

Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins

Tumor targeting is a booming business: The global therapeutic monoclonal antibody market accounted for more than $78 billion in 2012 and is expanding exponentially. Tumors can be targeted with an extensive arsenal of monoclonal antibodies, ligand proteins, peptides, RNAs, and small molecules. In add...

Full description

Bibliographic Details
Main Authors: Boonstra, Martin C., de Geus, Susanna W.L., Prevoo, Hendrica A.J.M., Hawinkels, Lukas J.A.C., van de Velde, Cornelis J.H., Kuppen, Peter J.K., Vahrmeijer, Alexander L., Sier, Cornelis F.M.
Format: Online
Language:English
Published: Libertas Academica 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040425/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040425/

Similar Items